Waters Integrates Acquisitions: Strong Synergies Drive Q1 Growth (WAT Q1 2026 Earnings Call)
Waters Corporation initiated a powerful new era of expansion in the first quarter of 2026, driven by rapid integration of acquired Biosciences and Diagnostic Solutions segments alongside strong legacy performance. CEO Udit Batra highlighted that legacy operations achieved double-digit organic constant currency growth, while newly acquired businesses outperformed management guidance. Bolstered by early operational improvements under a 180-day growth plan, the combined company achieved strong margin expansion and double-digit adjusted earnings growth. This initial success empowered management to raise the full-year organic constant currency revenue growth and adjusted earnings outlook, establishing a robust baseline for mid-teens long-term earnings growth.